As noted in previous Epstein Becker Green health reform alerts, on January 25, 2013, the long-awaited final omnibus rule (“Omnibus Rule”) issued by the U.S. Department of Health and Human Services (“HHS”) was published in the Federal Register. The Omnibus Rule makes sweeping changes to the privacy and security regulations under the Health Insurance Portability and Accountability Act (“HIPAA”).
In light of the Omnibus Rule’s new requirements, business associates and covered entities should strongly consider reviewing their existing HIPAA privacy and security practices, including compliance policies and business associate agreements. While the Omnibus Rule takes effect on March 26, 2013, affected parties have until September 23, 2013, to come into compliance with most of its provisions. This alert reviews several of the regulatory changes and suggests action items to facilitate compliance with the new requirements.
1. Review Business Associate Relationships, and Update Business Associate Agreements
The Omnibus Rule makes a number of significant changes to the definition of a “business associate.” The definition now expressly includes the following types of entities as business associates:
- Health information organizations, e-prescribing gateways, and entities that provide data transmission services for protected health information (“PHI”) to a covered entity and that require access to PHI on a routine basis;
- Entities that offer personal health records to individuals on behalf of a covered entity; and
- Subcontractors that create, receive, maintain, or transmit PHI on behalf of another business associate.
The preamble of the Omnibus Rule (“Preamble”) warns that the terms “health information organization” and “e-prescribing gateway” are illustrative and not intended to be an all-inclusive list of qualifying entities. On the other hand, the Preamble confirms a prior interpretation that “mere conduits” of information are not business associates, provided that they do not access PHI other than on a random or infrequent basis. The Preamble takes the position that entities that “manage the exchange of PHI through a network, including providing record locator services and performing various oversight and governance functions for an electronic health information exchange, have more than “random” access to PHI and, thus, would fall within the definition of a “business associate.”
As a result, in analyzing relationships with vendors to determine whether business associate covenants must be obtained, covered entities and “intermediate” business associates should look beyond mere naming conventions and make determinations regarding whether the data transmission organization has more than “random or infrequent” access to PHI.
Conversely, the Omnibus Rule provides clarification on entities that do not qualify as business associates (incorporating prior guidance) and specifically includes in the list:
- Providers receiving treatment-related PHI from a covered entity;
- Plan sponsors receiving PHI from group health plans;
- Government agencies determining eligibility for, or enrollment in, a government health plan providing public benefits that are administered by another government agency or that collect PHI for such purposes; and
- Covered entities participating in Organized Health Care Arrangements (“OHCA”) that perform certain services for, or on behalf of, an OHCA.
Of course, if a business associate relationship does exist, the business associate and covered entity need to enter into a business associate agreement. The Omnibus Rule imposes new requirements that must be addressed in business associate agreements. Key required covenants include a covenant to comply with the applicable provisions of the Security Rule; a covenant to report breaches of unsecured PHI to the covered entity; and a covenant to enter into written business associate agreements with any subcontractors. Therefore, entities that already have a business associate agreement in place will need to make sure that the agreement meets the specifications of the Omnibus Rule. HHS has posted sample language for doing so.
Business associates are charged with evaluating their relationships with vendors to determine whether a second- (or subsequent-) tier business associate agreement is required. Of course, any such second-tier business associate agreements must also reflect the requirements of the Omnibus Rule.
Covered entities and business associates should:
- review their business relationships to ensure that they have business associate agreements in place (including those needed with entities that now qualify as “business associates” under the newly expanded definition); and
- examine any current business associate agreements to ensure that they reflect the requirements of the Omnibus Rule.
2. Evaluate Compliance with Heightened Safeguard Requirements
The Omnibus Rule enhances business associates’ HIPAA obligations substantially. Business associates are now subject to civil monetary penalties for any violations. Specifically, under the Omnibus Rule, business associates are legally required to implement certain administrative safeguards, physical safeguards, and technical safeguards to protect the confidentiality, integrity, and availability of electronic PHI that they create, receive, maintain, or transmit (the requirements of the Security Rule).
In order to meet their responsibilities, business associates are now required to perform risk analyses. Such risk analyses must be accurate and thorough assessments of potential risks and vulnerabilities to the confidentiality, integrity, and availability of the electronic PHI that the business associate creates, receives, maintains, or transmits. The Security Rule also compels corrective actions to minimize any identified risks and vulnerabilities.
- Entities that previously qualified as business associates should review their HIPAA compliance programs to ensure that they are sufficiently robust to meet the new regulatory requirements.
- Those entities that newly qualify as business associates should develop and implement appropriate HIPAA compliance programs, including safeguards, policies, procedures, and document retention requirements.
3. Update Notices of Privacy Practices 
The Omnibus Rule requires covered entities to provide additional information in their Notices of Privacy Practices (“NPP”) as to how PHI will (and will not) be used and disclosed. The NPP must now include:
- A description of activities, involving uses or disclosures of PHI, that require an individual’s authorization, such as activities relating to the use of psychotherapy notes and disclosures of PHI for marketing purposes (in addition to the prior required statement that any uses or disclosures, other than those permitted, would be made only with an authorization);
- Notice that individuals have a right to opt out of receiving fundraising communications;
- A statement explaining that covered entities are required by law to notify affected individuals following a breach of unsecured PHI; and
- For covered entities that are health plans and intend to use PHI for underwriting purposes, a statement that the plan is prohibited from using or disclosing PHI that is genetic information of an individual for underwriting purposes.
The Omnibus Rule also eliminates certain content requirements. For example, the Omnibus Rule removes the requirement that covered entities’ NPPs notify individuals of any plans to contact individuals to provide appointment reminders or information about alternative treatment options.
The Omnibus Rule and Preamble are also instructive to covered entities regarding how such revised NPPs need to be made available to individuals. Specifically:
- For health plans:
- If the health plan posts its NPP on a website, then the plan must prominently post the change or the revised NPP on its website by the effective date of the change. Information on the revision or the revised NPP itself must also be provided to enrollees in its next annual mailing.
- If the health plan does not post its NPP on its website, then the plan must provide either the revised NPP or information about the change and how to obtain the revised NPP to enrollees within 60 days of the material revision.
- For providers:
- Providers should post the revised NPP at the site of service and have copies available for individuals to request.
- Providers must still provide new patients with a copy of the revised NPP.
Covered entities should:
- make sure that appropriate statements are included in the NPPs; and
- ensure that the revised NPP is posted as required under the Omnibus Rule.
4. Update Privacy Policies and Procedures.
The following are examples of policies and procedures that may need to be updated as a result of new requirements in the Omnibus Rule:
a. Authorization Forms and Related Policies
In the new HIPAA landscape, covered entities are required to obtain an authorization for any disclosure of PHI that constitutes a sale of PHI. Such authorization must state that the disclosure will result in remuneration to the covered entity.
On the other hand, the Omnibus Rule liberalized aspects of research authorizations. Specifically, an authorization for the use or disclosure of PHI for a research study may be combined with any other type of written permission for the same or another research study. This includes combining an authorization for the use or disclosure of PHI for a research study with another authorization for the same research study, with an authorization for the creation or maintenance of a research database or repository, or with a consent to participate in research. Certain restrictions apply when a provider has conditioned the provision of research-related treatment on the provision of an authorization.
Additionally, the Omnibus Rule liberalizes a few types of uses and disclosures that do not require an authorization. Under the Omnibus Rule, covered entities may now disclose PHI about students and prospective students to a school if the PHI is limited to proof of immunization that the school is legally required to have, and the covered entity obtained agreement for the disclosure from the individual or the individual’s parent or guardian.
Covered entities that are providers should:
- review their authorization policies to ensure that they accurately reflect the new requirements;
- review and revise any research authorizations; and
- draft policies regarding the disclosure of immunization information.
b. Procedures for Using PHI for Fundraising
Under the Omnibus Rule, covered entities may still use and disclose certain PHI for fundraising purposes. However, such use and disclosure is subject to several new conditions. First, covered entities must state their intention to use certain PHI for fundraising purposes in their NPPs. Second, each fundraising communication must provide the recipient with a clear and conspicuous opportunity to elect not to receive future communications. Third, covered entities may not condition treatment or payment on individuals’ decisions to receive fundraising communications.
Covered entities should:
- make sure that fundraising communications contain clear, conspicuous instructions for recipients regarding how to opt out from receiving future fundraising communications; and
- ensure that they maintain an adequate system to track individuals who opted out of receiving future fundraising communications.
c. Marketing Policy
The Omnibus Rule also makes certain changes to the definition of “marketing.” These changes are important because they inform when authorizations are required. Typically, a covered entity must obtain an authorization for the use or disclosure of PHI for marketing purposes, unless the communication is a face-to-face communication between the covered entity and an individual, or a promotional gift of nominal value provided by the covered entity. As described below, if the marketing involves financial remuneration to the covered entity from a third party, this use or disclosure will require the individual’s authorization.
Generally, “marketing” means communications about a product or service that encourage recipients of the communication to purchase or use the product or service. However, there are many exceptions. One new exception is that “marketing” does not include a communication made to provide refill reminders or communicate about a drug currently being described to the individual if financial remuneration received by the covered entity is reasonably related to the cost of the communication. Excepted purposes also include case management and care coordination, but the Omnibus Rule now limits them to instances where the covered entity does not receive financial remuneration in exchange for the communication. Likewise, uses or disclosures to describe a health-related product or service available only to a health plan enrollee that add value to, but are not part of, a plan of benefits remain permissible, unless the covered entity receives financial remuneration in exchange for the communication. Note that, as used to define “marketing,” the term “financial remuneration” means direct or indirect payment from or on behalf of a third party whose product or service is being described, and it does not include payment for treatment.
Covered entities and business associates should:
- update their marketing policies with the new definitions;
- update their marketing authorizations as appropriate; and
- obtain any necessary new marketing authorizations.
d. Access Policy
The Omnibus Rule also expands the rights of individuals to access their own PHI. Pursuant to the Omnibus Rule, if an individual requests an electronic copy of PHI maintained electronically in a designated record set from a covered entity, the covered entity must provide access to the PHI in the electronic form and format requested if readily producible. If not readily producible in such format, then the covered entity must provide the PHI in a readable electronic form and format that the parties find to be mutually agreeable. Additionally, the Omnibus Rule permits individuals to instruct covered entities to transmit copies of PHI directly to another designated person, and covered entities must abide by such requests that are in writing and signed and clearly identify the recipient.
Covered entities should update their policies regarding the provision of access to individuals’ PHI to accord with the Omnibus Rule.
5. Update Policies Regarding Determination of Breaches of Unsecured PHI
The Omnibus Rule implements a new definition of the term “breach of unsecured PHI.” Specifically, there is a new presumption that an unauthorized use or disclosure of unsecured PHI constitutes a breach unless the covered entity or business associate demonstrates a low probability that the PHI has been compromised. Thus, entities will no longer be able to conduct analyses to determine whether uses or disclosures of PHI pose a significant risk of harm to individuals. Under the Omnibus Rule, organizations must instead analyze the following:
- The nature and extent of PHI involved in the use or disclosure, including the types of identifiers and the likelihood of re-identification;
- The unauthorized entity to whom the PHI was disclosed or who used the PHI;
- Whether the PHI was actually acquired or viewed; and
- The extent to which the risk to the PHI has been mitigated.
Covered entities and business associates should:
- review and revise policies related to breach notification to include the new definition of “breach of unsecured PHI” and the new standards regarding when notification is required;
- amend internal instructions for sending out notifications; and
- retrain employees regarding what now constitutes a breach.
6. Update HIPAA Training
In order to implement all the changes discussed in this alert, covered entities and business associates will need to update the HIPAA training of their workforces. Employees, volunteers, and consultants need to understand that there are new rules to be applied when using, disclosing, and protecting PHI. Training is a vital step to achieving and maintaining compliance, in addition to being an independently required element of the Omnibus Rule.
Covered entities and business associates must amend policies, procedures, and business associate agreements to account for the changes affected by the Omnibus Rule. In addition, personnel must be trained to understand the revised parameters of the Omnibus Rule and to adopt the new preventative measures dictated by the Omnibus Rule. Beginning the process prior to the September 2013 deadline will ease the transition into the new HIPAA privacy and security compliance landscape.
* * *
For more information about this issue of IMPLEMENTING HEALTH AND INSURANCE REFORM, please contact the author below or the member of the firm who normally handles your legal matters:
Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notification Rules Under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules Published January 25, 2013
 Modifications to the HIPAA Privacy, Security, Enforcement and Breach Notification Rules under the Health Information Technology for Economic and Clinical Health Act and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA Rules; Department of Health and Human Services, Office of the Secretary (45 C.F.R. Parts 160 and 164), 78 Fed. Reg. 5566 (Jan. 25, 2013).
 See 45 C.F.R. §160.103.
 78 Fed. Reg. 5571.
 HHS posted sample business associate agreement provisions at http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/contractprov.html.
 See 45 C.F.R. §160.102.
 See 45 C.F.R. §164.520.
 See 45 C.F.R. §164.520; 78 Fed. Reg. 5622.
 See 45 C.F.R. §164.520(b)(iii)(C).
 See 45 C.F.R. §164.508(a)(3).
 See 45 C.F.R. §164.520(c)(2)(v).
 78 Fed. Reg. 5625.
 See 45 C.F.R. §164.508.
 See 45 C.F.R. §164.508(a)(4).
 See 45 C.F.R. §164.508(b)(3)(i).
 See 45 C.F.R. §164.514.
 See 45 C.F.R. §164.501.
 See45 C.F.R. §164.508(a)(3).
 See 45 C.F.R. §164.524(c).
See45 C.F.R. §164.402.